Biomax data-mining subsidiary, Viscovery Software, has launched version 7.2 of its Viscovery® SOMine® visual data mining suite. The new version offers a set of features for improved performance in Big Data preprocessing, as well as for advanced annotation and interpretation of explorative models on multiple semantic levels.

Viscovery SOMine suite v7.2 comes with considerable performance improvements for preprocessing of Big Data. By using single-instance caching in data and model processing, the runtime for applying bulky definitions of nominal variables has been significantly reduced.

Annotation of the map with textual labels has been extended to allow thumbnails. For example, an associated image document, such as a photo, can be displayed at the location in the Viscovery map to which a patient has been classified. Another new feature allows users to manage labels, group them hierarchically, and hide or show these groupings. This helps users annotate and interpret the Viscovery map on different semantic levels.

The complete list of innovations is available at www.viscovery.net/data-sheets.

About Viscovery

Viscovery Software GmbH, one of the first data-mining companies in Europe, is a leading vendor of predictive analytics software. Viscovery products are used by numerous customers worldwide in the fields of finance, telecommunications, industry, life-sciences media and retail, as well as at research organizations and universities. Since 2007, Viscovery has been the data-mining specialist of the Munich-based Biomax group, which provides data analysis and knowledge management in the life sciences. The Viscovery SOMine suite offers unique, patented technology for explorative analysis and predictive modeling of complex data using the combined power of self-organizing maps and multivariate statistics. www.viscovery.net

Über die Labvantage – Biomax GmbH

Biomax provides computational solutions for better decision making and knowledge management in the life sciences. They help customers generate value by integrating information from proprietary and public resources to enable a knowledge-based approach to developing innovative life science products. Biomax’s worldwide customer community includes companies and research organizations that are successful in drug discovery, diagnostics, fine chemicals, food and plant production. More information is available at www.biomax.com.

Firmenkontakt und Herausgeber der Meldung:

Labvantage – Biomax GmbH
Robert-Koch-Str. 2
82152 Planegg
Telefon: +49 (89) 895574-0
Telefax: +49 (89) 895574-825
http://www.biomax.com

Ansprechpartner:
Frank Zimmermann
Director Business Development
Telefon: +49 (89) 895574-865
Fax: +49 (89) 895574-825
E-Mail: frank.zimmermann@biomax.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel